Loading...
•
Dec 31, 2022
Thermo Fisher Q4 2022 Earnings Report
Reported a 7% increase in revenue, reaching $11.45 billion, and an adjusted EPS of $5.40.
Key Takeaways
Thermo Fisher Scientific reported strong fourth-quarter results, with revenue growing 7% to $11.45 billion and adjusted EPS reaching $5.40. The company highlighted its continued investment in innovation and capacity expansion, as well as its progress on ESG priorities.
Fourth quarter revenue grew 7% to $11.45 billion.
Fourth quarter GAAP diluted earnings per share (EPS) was $4.01.
Fourth quarter adjusted EPS was $5.40.
Core organic revenue growth was 14%.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
Thermo Fisher is initiating revenue and adjusted EPS guidance for the full year 2023. The company expects to achieve 2023 revenue of $45.3 billion and full year Core organic revenue growth of 7%. The company expects to achieve adjusted EPS of $23.70.
Revenue & Expenses
Visualization of income flow from segment revenue to net income